{"schema_version":"secwatch.filing_event.v1","accession":"0001730463-25-000046","form_type":"8-K","ticker":"AUTL","cik":"0001730463","company_name":"Autolus Therapeutics plc","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.504975+00:00","generated_at":"2026-05-18T16:11:20.676102+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Autolus Therapeutics announces results of 2025 Annual General Meeting, all resolutions passed","bullets":["Resolution 1 (adopt 2024 accounts): 219,809,664 for, 97,503 against, 477,332 abstain.","Resolution 2 (approve directors' remuneration report): 216,036,710 for, 4,285,817 against.","Resolution 5 (re-elect Dr. R. Iannone as director): 199,042,000 for, 20,750,286 against.","Resolution 7 (approve Employee Share Purchase Plan with 3,000,000 shares): 219,651,874 for, 706,780 against.","All nine ordinary resolutions were duly passed on a poll."],"urls":{"canonical":"https://secwatch.observer/filing/0001730463-25-000046","json":"https://secwatch.observer/filing/0001730463-25-000046.json","markdown":"https://secwatch.observer/filing/0001730463-25-000046.md","text":"https://secwatch.observer/filing/0001730463-25-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000046/0001730463-25-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1730463/000173046325000046/autl-20250626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T16:11:20.676102+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}